What is TLRY (TLRY) stock price today?

TLRY (TLRY) is currently trading at $4.03, up 3.87% today.

What is TLRY P/E ratio?

TLRY's P/E ratio is 18.71. This is near the market average.

What is TLRY return on equity (ROE)?

TLRY's return on equity (ROE) is -63.16%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is TLRY's market cap?

TLRY has a market capitalization of $483.61M.

NASDAQ · Drug Manufacturers - Specialty & Generic

TLRY (TLRY) Stock

$4.03 +3.87% NASDAQ: TLRY Healthcare

Valuation

Metric	Value
Price	$4.03
Market Cap	$483.61M
P/E Ratio	18.71
P/B Ratio	1.68
P/S Ratio	0.51
EPS (TTM)	$0.27
52-Week High	$23.20
52-Week Low	$3.50
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-63.16%
ROA	-1.47%
ROCE	-153.23%
Gross Margin	27.67%
Operating Margin	-1.72%
Net Margin	-1.56%
Debt/Equity	0.20
Current Ratio	2.45

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$620.0M	$792.0M	$845.0M	$1.1B	$1.1B
Operating Profit	$-160.0M	$-769.0M	$-1.8B	$-238.0M	$-3.1B
Net Profit	$-444.0M	$-601.0M	$-2.0B	$-334.0M	$-3.0B
EPS	$-13.61	$-9.94	$-31.70	$-4.50	$-33.80
Op Margin	-25.8%	-97.1%	-218.4%	-22.1%	-277.9%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$6.0B	$6.9B	$5.9B	$5.9B	$2.9B
Total Liabilities	$1.6B	$1.3B	$1.4B	$1.2B	$860.0M
Cash	$488.0M	$524.0M	$278.0M	$311.0M	$304.0M
Borrowings	$939.0M	$786.0M	$795.0M	$528.0M	$451.0M

Latest News

PSKY, ORCL, TLRY Stocks Hit 52-Week Lows Today: What's Driving The Selloff? Stocktwits · Jul 21, 2026 Tilray Brands, Inc. (TLRY) Declines More Than Market: Some Information for Investors Zacks · Jul 20, 2026 Should You Buy Tilray Brands Stock Before July 28? Motley Fool · Jul 20, 2026 Tilray Brands' BrewDog Kicks Off 1 Million Pound Bar Tab in The UK MT Newswires · Jul 17, 2026 BrewDog and Tilray Brands Unlock £1 Million Bar Tab for Football Fans Across England, Scotland and Ireland GlobeNewswire · Jul 17, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-54.0M	$-223.0M	$11.0M	$-42.0M	$-130.0M
Investing Cash Flow	$9.0M	$-70.0M	$-412.0M	$135.0M	$-109.0M
Financing Cash Flow	$-30.0M	$-19.0M	$-3.0M	$-4.0M	$-6.0M
Net Cash Flow	$473.0M	$-91.0M	$-282.0M	$30.0M	$-9.0M
Free Cash Flow	$-101.0M	$-266.0M	$-17.0M	$-82.0M	$-175.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	—
EV / EBITDA	120.86
FCF Yield	-15.76%
Quick Ratio	1.66
Interest Coverage	-54.95
Return 1Y	-46.08%
Return 3Y	-76.39%
Return 5Y	-96.96%

Ownership

Insiders Held0.72%

Institutions Held9.35%

Institutions Float Held9.42%

Institutional Holder	Shares	Report Date
Tidal Investments LLC	2,563,689	2026-03-31
UBS Group AG	653,001	2026-03-31
Morgan Stanley	641,025	2026-03-31
Susquehanna International Group, LLP	542,232	2026-03-31
Mirae Asset Global ETFs Holdings Ltd.	486,820	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ALVOAlvotech	$3.16	+3.10%	-10.76	$1.07B	0.00%
AMPH	$20.22	+1.40%	12.02	$891.56M	0.00%
DVAXDynavax Technologies Corporation	$15.50	+0.00%	-40.79	$1.82B	0.00%
EVOEvotec SE	$2.01	-6.07%	-3.26	$713.93M	0.00%
HROW	$39.09	+0.83%	14.50	$1.46B	0.00%

About TLRY

TLRY is led by CEO Irwin David Simon, employs 2,650 people, headquartered in CA, publicly traded since 2018.

TLRY stock trades at $4.03 with a market capitalization of $483.61M. The stock is valued at a price-to-earnings (P/E) ratio of 18.71, price-to-book of 1.68, price-to-sales of 0.51. Over the past 52 weeks the stock has ranged between $3.50 and $23.20, and currently trades 82.6% below its 52-week high.

On profitability, TLRY generates a return on equity (ROE) of -63.16%, return on capital employed of -153.23%, an operating margin of -1.72%, a net profit margin of -1.56%.

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides